Literature DB >> 33531589

Sarcoplasmic reticular Ca2+-ATPase inhibition paradoxically upregulates murine skeletal muscle Nav1.4 function.

Sean X Liu1, Hugh R Matthews1, Christopher L-H Huang2,3.   

Abstract

Skeletal muscle Na+ channels possess Ca2+- and calmodulin-binding sites implicated in Nav1.4 current (INa) downregulation following ryanodine receptor (RyR1) activation produced by exchange protein directly activated by cyclic AMP or caffeine challenge, effects abrogated by the RyR1-antagonist dantrolene which itself increased INa. These findings were attributed to actions of consequently altered cytosolic Ca2+, [Ca2+]i, on Nav1.4. We extend the latter hypothesis employing cyclopiazonic acid (CPA) challenge, which similarly increases [Ca2+]i, but through contrastingly inhibiting sarcoplasmic reticular (SR) Ca2+-ATPase. Loose patch clamping determined Na+ current (INa) families in intact native murine gastrocnemius skeletal myocytes, minimising artefactual [Ca2+]i perturbations. A bespoke flow system permitted continuous INa comparisons through graded depolarizing steps in identical stable membrane patches before and following solution change. In contrast to the previous studies modifying RyR1 activity, and imposing control solution changes, CPA (0.1 and 1 µM) produced persistent increases in INa within 1-4 min of introduction. CPA pre-treatment additionally abrogated previously reported reductions in INa produced by 0.5 mM caffeine. Plots of peak current against voltage excursion demonstrated that 1 µM CPA increased maximum INa by ~ 30%. It only slightly decreased half-maximal activating voltages (V0.5) and steepness factors (k), by 2 mV and 0.7, in contrast to the V0.5 and k shifts reported with direct RyR1 modification. These paradoxical findings complement previously reported downregulatory effects on Nav1.4 of RyR1-agonist mediated increases in bulk cytosolic [Ca2+]. They implicate possible local tubule-sarcoplasmic triadic domains containing reduced [Ca2+]TSR in the observed upregulation of Nav1.4 function following CPA-induced SR Ca2+ depletion.

Entities:  

Year:  2021        PMID: 33531589     DOI: 10.1038/s41598-021-82493-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  3 in total

1.  EF hand-like motif mutations of Nav1.4 C-terminus cause myotonic syndrome by impairing fast inactivation.

Authors:  Riho Horie; Tomoya Kubota; Jinsoo Koh; Rieko Tanaka; Yuichiro Nakamura; Ryogen Sasaki; Hidefumi Ito; Masanori P Takahashi
Journal:  Muscle Nerve       Date:  2020-03-04       Impact factor: 3.217

2.  Ca2+-dependent regulation of sodium channels NaV1.4 and NaV1.5 is controlled by the post-IQ motif.

Authors:  Jesse B Yoder; Manu Ben-Johny; Federica Farinelli; Lakshmi Srinivasan; Sophie R Shoemaker; Gordon F Tomaselli; Sandra B Gabelli; L Mario Amzel
Journal:  Nat Commun       Date:  2019-04-03       Impact factor: 14.919

Review 3.  Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison.

Authors:  Gildas Loussouarn; Damien Sternberg; Sophie Nicole; Céline Marionneau; Francoise Le Bouffant; Gilles Toumaniantz; Julien Barc; Olfat A Malak; Véronique Fressart; Yann Péréon; Isabelle Baró; Flavien Charpentier
Journal:  Front Pharmacol       Date:  2016-01-14       Impact factor: 5.810

  3 in total
  3 in total

Review 1.  Ca2+-dependent modulation of voltage-gated myocyte sodium channels.

Authors:  Samantha C Salvage; Zaki F Habib; Hugh R Matthews; Antony P Jackson; Christopher L-H Huang
Journal:  Biochem Soc Trans       Date:  2021-11-01       Impact factor: 5.407

Review 2.  Excitation-contraction coupling in mammalian skeletal muscle: Blending old and last-decade research.

Authors:  Pura Bolaños; Juan C Calderón
Journal:  Front Physiol       Date:  2022-09-02       Impact factor: 4.755

3.  Finite element analysis predicts Ca2+ microdomains within tubular-sarcoplasmic reticular junctions of amphibian skeletal muscle.

Authors:  Oliver J Bardsley; Hugh R Matthews; Christopher L-H Huang
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.